You are here: Industry Insights > blood pressure

News List

FDA announces another carcinogenic impurity in ARB blood pressure drugs pharmaceutical-technology
March 05, 2019
The US Food and Drug Administration (FDA) has revealed that a third impurity has been found in generic angiotensin II receptor blocker (ARB) drugs indicated for high blood pressure and heart failure.
Samsung’s new smart watch has blood pressure function pharmaphorum
February 26, 2019
Samsung has followed the example of Apple and launched a smart watch with a focus on improving the wearer’s health.
Aurobindo Pharma Adds to Nationwide Valsartan Blood Pressure Medication Recall americanpharmaceuticalreview
January 14, 2019
Aurobindo Pharma is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of .....
Withings launches ECG watch to compete with Apple pharmaphorum
January 08, 2019
Apple has a new competitor to its smart watch-based electrocardiogram (ECG) sensor, after Withings announced a rival at the Consumer Electronics Show in Las Vegas.
Exercise Can Consistently Lower Blood Pressure drugs
January 08, 2019
Exercise can consistently yield reductions in blood pressure, according to a meta-analysis published online Dec. 18 in the British Journal of Sports Medicine.....
Novartis division Sandoz recalls one lot of blood pressure drug expressbpd
November 12, 2018
The drug is made by China’s Zhejiang Huahai Pharmaceutical
Novartis division Sandoz recalls one lot of blood pressure drug expressbpd
November 10, 2018
The drug is made by China’s Zhejiang Huahai Pharmaceutical. Last month, the European Medicines Agency placed the firm under high supervision after a probable carcinogen was found in its blood pressure drug valsartan.
Blue light can reduce blood pressure worldpharmanews
November 10, 2018
Researchers discovered that exposure to whole-body blue light significantly reduced the systolic blood pressure of participants by almost 8 mmHg, compared to the control light which had no impact. The reduction of blood pressure from blue light is similar
Blood pressure drug slows aortic dilatation in Marfan syndrome europeanpharmaceuticalreview
August 31, 2018
“Our finding of reduced aortic dilatation with irbesartan, over and above standard medical therapy, suggests an important clinical effect that may prevent complications and ultimately delay or obviate the need for surgical intervention in patients with Ma
Blood pressure and cholesterol lowering drugs continue to improve survival after a decade firstwordpharma
August 27, 2018
Munich, Germany – 26 Aug 2018: Blood pressure and cholesterol lowering drugs continue to improve survival in patients with hypertension after more than a decade......

Previous page 1 2 3 Next page